Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes.
Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation ...
(k) clearance enables immediate U.S. commercialization of enhanced soft tissue approximation technology in the gastrointestinal tract GOSSELIES, Belgium, March 17, 2026 /PRNewswire/ -- Endo ...
Peer-Reviewed Data Show Durable HbA1c Reduction, Significant Weight Loss, and a Favorable Safety Profile Through 48 Weeks Following a Single Endoscopic Procedure for Type 2 Diabetes ...
The global minimally invasive orthopedic procedures market is projected to grow at a CAGR of approximately 9% over the next ...
TAIPEI (Taiwan News) — A leatherback sea turtle rescued from a fishing net in Yilan died late Monday night despite a more ...